Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene

Vaccine

Volumn 24, Issue 44-46, 2006, Pages 6647-6650

  de Wit, Emmie ^a,b   Spronken, Monique I J ^a,b   Rimmelzwaan, Guus F ^a   Osterhaus, Albert D M E ^a   Fouchier, Ron A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Influenza A virus; Packaging; RNA polymerase II; trans complementation; Vaccine; Viral RNAs

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ARTICLE; DNA PACKAGING; GENETIC PROCEDURES; HUMAN; INFLUENZA VIRUS A; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ISOLATION; STRUCTURAL GENE; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION;

DEFECTIVE VIRUSES; DNA-DIRECTED RNA POLYMERASES; GENOME, VIRAL; INFLUENZA A VIRUS; RNA, VIRAL; VIRION; VIRUS ASSEMBLY;

EID: 33846204394     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.06.001     Document Type: Article

References (15)

1. Murphy B.R., and Webster R.G. Orthomyxoviruses. In: Howley P.M. (Ed). Virology. 3rd ed. vol. 1 (1996), Lippincott-Raven publishers, Philadelphia 1397-1445
2. Hirst G.K., and Pons M.W. Mechanism of influenza recombination II. Virus aggregation and its effect on plaque formation by so-called noninfective virus. Virology 56 (1973) 620-631
3. Martin K., and Helenius A. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67 (1991) 117-130
4. Enami M., Sharma G., Benham C., and Palese P. An influenza virus containing nine different RNA segments. Virology 185 (1991) 291-298
5. Bancroft C.T., and Parslow T.G. Evidence for segment-nonspecific packaging of the influenza A virus genome. J Virol 76 (2002) 7133-7139
6. Smith G.L., and Hay A.J. Replication of the influenza virus genome. Virology 118 (1982) 96-108
7. Duhaut S.D., and McCauley J.W. Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology 216 (1996) 326-337
8. Fujii Y., Goto H., Watanabe T., Yoshida T., and Kawaoka Y. Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci USA 100 (2003) 2002-2007 (Epub 2003, February 2006)
9. Watanabe T., Watanabe S., Noda T., Fujii Y., and Kawaoka Y. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol 77 (2003) 10575-10583
10. Fujii K., Fujii Y., Noda T., Muramoto Y., Watanabe T., Takada A., et al. Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol 79 (2005) 3766-3774
11. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97 (2000) 6108-6113
12. de Wit E., Spronken M.I., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., and Fouchier R.A. Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res 103 (2004) 155-161
13. Pleschka S., Jaskunas R., Engelhardt O.G., Zurcher T., Palese P., and Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J Virol 70 (1996) 4188-4192
14. Basler C.F., Wang X., Muhlberger E., Volchkov V., Paragas J., Klenk H.D., et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97 (2000) 12289-12294
15. Nicholson K.G., Colegate A.E., Podda A., Stephenson I., Wood J., Ypma E., et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357 9272 (2001) 1937-1943